Clinical Trials
12 trialsNCT07333976 2026-01-12
o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer
Tri-Service General Hospital
Phase 2 Completed
NCT04150913 2025-11-25
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
Massachusetts General Hospital
Phase 2 Completed
NCT00727922 2025-11-20
MnDPDP-K04
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT01399372 2023-07-20
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00792142 2021-08-19
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
City of Hope Medical Center
Phase 2 Completed
NCT01381718 2021-08-13
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
University of South Florida
Phase 2 Completed
NCT00952848 2017-03-29
Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy
Virginia Commonwealth University
Phase 2 Completed
NCT00365768 2016-09-09
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Columbia University
Phase 2 Completed
NCT01763710 2016-03-29
neurabrax
Fundacion Oncosur
Phase 2 Completed
NCT00666484 2014-12-04
Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma
University College, London
Phase 2 Completed
NCT00078845 2012-10-17
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00003072 2012-09-21
Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer
University of California, San Francisco
Phase 2 Completed